CDC: Someone in the U.S. dies of a drug-resistant superbug every 15 minutes

The report put five superbugs on the 'urgent threat' list


 Every 15 minutes, someone in the United States dies of a superbug according to a new report from the US Centers for Disease Control and Prevention.

That’s about 35,000 deaths each year from drug-resistant infections, according to an article on the KFOR website.

The report put five superbugs on the "urgent threat" list — two more germs than were on the list in 2013. The two new ones are carbapenem-resistant Acinetobacter and Candida auris.

The report also notes that while superbug infections in hospitals are down, some infections caught elsewhere — anywhere in the community — have increased.

Read the article.



December 3, 2019


Topic Area: Infection Control


Recent Posts

EV Charging Stations: Planning for Safety, Convenience, Expansion

Managers need to ensure patient access, coordinate with clinical operations and ensure every phase of construction supports the facility's mission.


Why Ambulatory Surgery Centers Are Turning to Dedicated HVAC Systems

Design experts from Neenan Archistruction explain how single-unit HVAC systems for each operating room enhance infection control, comfort, and resiliency.


Ground Broken on UW Health University Row Medical Center

Construction is expected to be completed by the end of 2027.


Better, More Thorough Cleaning Saves Lives

Cleanliness is the first line of defense to protect patients from killer pathogens, but many hospitals refuse to make it a priority.


Encompass Health Opens the Rehabilitation Hospital of Amarillo

The 50-bed inpatient rehabilitation hospital is now accepting patients.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.